EP 3174899 A1 20170607 - ANTIBODIES FOR TREATMENT AND DIAGNOSIS
Title (en)
ANTIBODIES FOR TREATMENT AND DIAGNOSIS
Title (de)
ANTIKÖRPER ZUR BEHANDLUNG UND DIAGNOSE
Title (fr)
ANTICORPS UTILISÉS À DES FINS DE TRAITEMENT ET DE DIAGNOSTIC
Publication
Application
Priority
- GB 201413357 A 20140728
- EP 2015067309 W 20150728
Abstract (en)
[origin: WO2016016265A1] The invention relates to the diagnosis and treatment of diseases, including cancer and inflammatory disorders. The invention provides, and involves the use of, antibodies that bind: i) the IIICS isoform of fibronectin, ii) matrix-metalloproteinase 3 (MMP3), iii) periostin, or iv) tenascin-W.
IPC 8 full level
C07K 16/18 (2006.01)
CPC (source: EP US)
A61K 39/3955 (2013.01 - US); A61K 47/6843 (2017.08 - EP US); A61K 47/6851 (2017.08 - US); A61K 49/0004 (2013.01 - US); A61K 51/1018 (2013.01 - US); A61P 35/00 (2018.01 - EP US); C07K 16/18 (2013.01 - EP US); C07K 16/40 (2013.01 - EP US); G01N 33/564 (2013.01 - EP US); G01N 33/574 (2013.01 - EP US); A61K 2039/505 (2013.01 - US); C07K 2317/33 (2013.01 - EP US); C07K 2317/565 (2013.01 - US); C07K 2317/92 (2013.01 - EP US)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2016016265 A1 20160204; CA 2992136 A1 20160204; CA 2992136 C 20200630; EP 3174899 A1 20170607; EP 3174900 A1 20170607; GB 201413357 D0 20140910; JP 2017526654 A 20170914; JP 2017530092 A 20171012; JP 6577016 B2 20190918; US 10098976 B2 20181016; US 10125190 B2 20181113; US 2017226196 A1 20170810; US 2018193496 A1 20180712; WO 2016016269 A1 20160204
DOCDB simple family (application)
EP 2015067309 W 20150728; CA 2992136 A 20150728; EP 15744195 A 20150728; EP 15744198 A 20150728; EP 2015067314 W 20150728; GB 201413357 A 20140728; JP 2017504375 A 20150728; JP 2017504376 A 20150728; US 201515329222 A 20150728; US 201515329223 A 20150728